Send the following on WhatsApp
Continue to Chathttps://de.marketscreener.com/kurs/aktie/QUANTUM-GENOMICS-16253203/news/Quantum-Genomics-gibt-das-Ende-der-Patientenrekrutierung-fur-seine-Phase-III-Zulassungsstudie-FRESH-40329768/?utm_source=whatsapp&utm_medium=social&utm_campaign=share